These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32459110)

  • 1. Early administration of tirofiban after urokinase-mediated intravenous thrombolysis reduces early neurological deterioration in patients with branch atheromatous disease.
    Liu B; Zhang H; Wang R; Qu H; Sun Y; Zhang W; Zhang S
    J Int Med Res; 2020 May; 48(5):300060520926298. PubMed ID: 32459110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
    Mangiafico S; Cellerini M; Nencini P; Gensini G; Inzitari D
    Stroke; 2005 Oct; 36(10):2154-8. PubMed ID: 16141418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.
    Wu C; Sun C; Wang L; Lian Y; Xie N; Huang S; Zhao W; Ren M; Wu D; Ding J; Song H; Wang Y; Ma Q; Ji X
    Stroke; 2019 Dec; 50(12):3481-3487. PubMed ID: 31570084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
    Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tirofiban in patients with acute branch atheromatous disease-related stroke (BRANT): a protocol for a randomised controlled trial.
    Li S; Zhang D; Sha Y; Zhu Y; Zhou L; Peng B; Ni J
    BMJ Open; 2024 Jun; 14(6):e082141. PubMed ID: 38858147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
    Zhao W; Li S; Li C; Wu C; Wang J; Xing L; Wan Y; Qin J; Xu Y; Wang R; Wen C; Wang A; Liu L; Wang J; Song H; Feng W; Ma Q; Ji X;
    JAMA Neurol; 2024 Jun; 81(6):594-602. PubMed ID: 38648030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of intravenous thrombolysis with tenecteplase on patients with post awakening branch atheromatous disease].
    Hu SJ; Fu SS; Zhu LL; Yu M; Song L; Qin HQ
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(23):2173-2178. PubMed ID: 38871476
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration.
    Du Y; Li Y; Duan Z; Ma C; Wang H; Liu R; Li S; Lian Y
    J Clin Pharm Ther; 2022 Dec; 47(12):2350-2359. PubMed ID: 36461632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients.
    Zhang H; Lin F; Zhao Y; Chang W; Liu H; Yin J; Li L
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):448-452. PubMed ID: 34117180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
    Kim JW; Jeon P; Kim GM; Bang OY; Byun HS; Kim KH
    Clin Neurol Neurosurg; 2012 Dec; 114(10):1316-9. PubMed ID: 22633401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS).
    Liu Y; Li S; Hao D; Zhang Z; Yi Y; Fang J; Lin W; Zhang M
    Front Neurosci; 2022; 16():1026127. PubMed ID: 36466171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous tirofiban therapy for patients with capsular warning syndrome.
    Li W; Wu Y; Li XS; Liu CC; Huang SH; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Zhang M
    Stroke Vasc Neurol; 2019 Mar; 4(1):22-27. PubMed ID: 31105975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tirofiban in the treatment of cancer-associated ischemic stroke.
    Zhang ZM; Lin ZH; Zhu GL
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3590-3596. PubMed ID: 37140310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
    Lin L; Li W; Liu CC; Wu Y; Huang SH; Li XS; Liang CR; Wang H; Zhang LL; Xu ZQ; Wang YJ; Feng W; Zhang M
    J Neurol Sci; 2017 Dec; 383():175-179. PubMed ID: 29246609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Brain Atrophy on Early Neurological Deterioration and Outcome in Severe Ischemic Stroke Treated by Intravenous Thrombolysis.
    Tschirret O; Moreno Legast G; Mansuy A; Mewton N; Buisson M; Hannoun S; Chamard L; Sappey-Marinier D; El Khoury C; Bischoff M; de Parisot A; Derex L; Nighoghossian N; Berthezène Y; Mechtouff L
    Eur Neurol; 2018; 79(5-6):240-246. PubMed ID: 29672312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of intravenous thrombolysis with tenecteplase in treating the branch atheromatous disease].
    Fu SS; Zhu LL; Li HR; Zhou XY; Yu M; Qin HQ
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(23):1753-1758. PubMed ID: 37305934
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous Glycoprotein IIb/IIIa Inhibitor (Tirofiban) Followed by Low-Dose Intra-Arterial Urokinase and Mechanical Thrombolysis for the Treatment of Acute Stroke.
    Ihn YK; Sung JH; Kim BS
    Neuroradiol J; 2011 Dec; 24(6):907-13. PubMed ID: 24059896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.